To study the potential role of TROP2 in the development of COPD, immunohistochemistry was used to compare TROP2 expression in lung tissue samples from smokers with COPD, smokers without COPD and nonsmokers (Fig. 1a). This evidence concerns the gene TACSTD2 and chronic obstructive pulmonary disease.